Cargando…
Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges
The COVID-19 pandemic has presented challenges for traditional models of opioid use disorder treatment worldwide. Depot buprenorphine became available in Australia shortly before the height of the COVID-19 pandemic. This timing provided us an opportunity to examine the utilization and uptake of depo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711199/ https://www.ncbi.nlm.nih.gov/pubmed/33303254 http://dx.doi.org/10.1016/j.jsat.2020.108221 |